Cholinergic control of inflammation
Open Access
- 7 May 2009
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 265 (6), 663-679
- https://doi.org/10.1111/j.1365-2796.2009.02098.x
Abstract
Cytokine production is necessary to protect against pathogens and promote tissue repair, but excessive cytokine release can lead to systemic inflammation, organ failure and death. Inflammatory responses are finely regulated to effectively guard from noxious stimuli. The central nervous system interacts dynamically with the immune system to modulate inflammation through humoral and neural pathways. The effect of glucocorticoids and other humoral mediators on inflammatory responses has been studied extensively in the past decades. In contrast, neural control of inflammation has only been recently described. We summarize autonomic regulation of local and systemic inflammation through the ‘cholinergic anti‐inflammatory pathway’, a mechanism consisting of the vagus nerve and its major neurotransmitter, acetylcholine, a process dependent on the nicotinic acetylcholine receptor α7 subunit. We recapitulate additional sources of acetylcholine and their contribution to the inflammatory response, as well as acetylcholine regulation by acetylcholinesterase as a means to attenuate inflammation. We discuss potential therapeutic applications to treat diseases characterized by acute or chronic inflammation, including autoimmune diseases, and propose future research directions.Keywords
This publication has 119 references indexed in Scilit:
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- Cholinergic agonists attenuate renal ischemia–reperfusion injury in ratsKidney International, 2008
- Cytokine Signaling Modules in Inflammatory ResponsesImmunity, 2008
- Understanding NF‐κB signaling via mathematical modelingMolecular Systems Biology, 2008
- The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammationBritish Journal of Pharmacology, 2007
- Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7Clinical and Experimental Immunology, 2006
- Role of HMGB1 in apoptosis-mediated sepsis lethalityThe Journal of Experimental Medicine, 2006
- Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsisThe Journal of Experimental Medicine, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002